The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Keros Therapeutics Inc (NASDAQ: KROS) closed the day trading at $13.71 down -0.36% from the previous closing price of $13.76. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 1.0 million shares were traded.
Ratios:
For a better understanding of KROS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.45 and its Current Ratio is at 21.45. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On January 17, 2025, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $15.
Oppenheimer reiterated its Outperform rating for the stock on December 16, 2024, while the target price for the stock was revised from $102 to $63.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 09 ’25 when ADAR1 Capital Management, LLC bought 934,258 shares for $10.13 per share. The transaction valued at 9,464,512 led to the insider holds 4,392,737 shares of the business.
GORDON CARL L sold 250,000 shares of KROS for $11,002,500 on Aug 13 ’24. The Director now owns 119,522 shares after completing the transaction at $44.01 per share. On Aug 13 ’24, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 250,000 shares for $44.01 each. As a result, the insider received 11,002,500 and left with 119,522 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 156.84 while its Price-to-Book (P/B) ratio in mrq is 0.97.
Stock Price History:
Over the past 52 weeks, KROS has reached a high of $72.37, while it has fallen to a 52-week low of $9.12. The 50-Day Moving Average of the stock is 13.50%, while the 200-Day Moving Average is calculated to be -60.12%.
Shares Statistics:
A total of 40.55M shares are outstanding, with a floating share count of 32.87M. Insiders hold about 19.05% of the company’s shares, while institutions hold 91.65% stake in the company.
